Search

everythinglearnresearchcommunity

for

Search:↓

Skin problems in COVID-19 patients are rare and may be due to the body's complex immune response or blood clotting issues.

Female pattern hair loss involves hormonal factors, genetics, and may be linked to low ferritin levels.

Sex hormone treatments can increase muscle mass in older adults but have inconsistent effects on muscle function and may carry cardiovascular risks.

FPHL common in Taiwanese women; risk factors include BMI, high glucose, early puberty, fewer childbirths, oral contraceptives, and UV exposure.

Hair loss in elderly women is often caused by various factors, including hormonal changes after menopause.

Testosterone may have a dual role in COVID-19, potentially worsening outcomes in men, and testosterone therapy could help some patients, but more research is needed.

Hormones and genes affect hair growth and male baldness.

Treat pattern hair loss with finasteride and topical minoxidil.

Researchers created immortal human skin cells with constant testosterone receptor activity to study hair loss and test treatments.

Cuscuta reflexa extracts and an isolate promoted hair growth and could be natural treatments for hair loss.

Exemestane is effective and safe for treating certain breast cancers, with mild side effects, but needs more research on long-term effects.

Most women with hirsutism have it because of PCOS, and they need long-term treatment including medication and hair removal to improve their condition.

Finasteride reduces prostate cancer risk by 30% without affecting Gleason scores.

KGF and its receptor are found in enlarged prostate tissue and KGF strongly increases cell growth.

Hair ages due to various factors and treatments like minoxidil and finasteride can help, but more research and better public awareness are needed.

Collagen networks play a key role in hair loss and follicle miniaturization.

Personalized treatments for hair loss focus on specific genetic and biological pathways.

High TNF-α levels may increase hair loss risk after PRP therapy.

New treatments for hair loss include low-dose oral minoxidil, light therapy, and innovative therapies targeting hair growth mechanisms.

Diagnosing Sertoli-Leydig cell tumors is challenging due to their unusual symptoms and can occur at any age.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

New drug shows promise for better hair growth in baldness treatment.

Steroid hormones are crucial for body functions and have various medical uses, but their misuse can lead to dependence.

ADT, especially enzalutamide, may increase the risk of heart rhythm problems and sudden death in men.

About 7% to 15% of Iranian women have polycystic ovary syndrome, depending on the criteria used to diagnose it.

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.

The enzyme steroid sulfatase is linked to breast cancer and other conditions, and inhibitors are being developed for treatment.

Early diagnosis and treatment, using finasteride, minoxidil, or hair transplantation, improves hair loss outcomes.

Hair loss needs more research for better treatments.

Androgens can both stimulate and cause hair loss, and understanding their effects is key to treating hair disorders.